Evidence map›Paper›PMID 40077797›Full record

Observational studyNutrients2025

Nutritional Status and Its Impact on Treatment Tolerance in Non-Small-Cell Lung Cancer Patients Receiving Osimertinib.

Claudia Barca-Díez, Regina Palmeiro-Carballa, Susana Castro-Luaces, Maria Susana Fortes-González, Silvia Vazquez-Blanco, Noemi Martínez-López-De-Castro, Natividad Lago-Rivero

Abstract readObservational Study
In one paragraph

Observational study in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claudia Barca-DíezPharmacy Department, University Hospital Complex of Vigo, 36312 Vigo, Spain.
Regina Palmeiro-CarballaEndocrinology and Nutrition Department, University Hospital Complex of Vigo, 36312 Vigo, Spain.
Susana Castro-LuacesPharmacy Department, University Hospital Complex of Vigo, 36312 Vigo, Spain.
Maria Susana Fortes-GonzálezPharmacy Department, University Hospital Complex of Vigo, 36312 Vigo, Spain.
Silvia Vazquez-BlancoPharmacy Department, Hospital Ribera Povisa, 36211 Vigo, Spain.
Noemi Martínez-López-De-CastroPharmacy Department, University Hospital Complex of Vigo, 36312 Vigo, Spain.ORCID 0000-0002-5043-0741
Natividad Lago-RiveroPharmacy Department, University Hospital Complex of Vigo, 36312 Vigo, Spain.ORCID 0000-0002-3695-4864

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcrylamidesAniline CompoundsAntineoplastic AgentsCarcinoma, Non-Small-Cell LungLung NeoplasmsNutritional StatusProtein Kinase InhibitorsAgedBody CompositionCross-Sectional StudiesFemaleHumansIndolesMaleMalnutritionMiddle AgedAcrylamidesAniline CompoundsAntineoplastic AgentsIndolesosimertinibProtein Kinase InhibitorsPyrimidinesbody compositiondose-limiting toxicitiesdynapeniamalnutritionnon-small-cell lung cancerosimertinibsarcopenia

Identifiers

PMID40077797
PMCPMC11901973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.